Docs back moratorium on drug ads: survey

Share this article:
A solid majority of doctors - 64% - say there should be some sort of moratorium on DTC advertising, according to a survey by TNS Healthcare.

Almost half of physicians - 44% - would approve of a moratorium of two years or more, and 27% believe there should be no DTC ads at all.

The survey of 1,002 physicians and 251 consumers found physician attitudes toward DTC far harsher than those of the general public. Only 44% of consumers favored a moratorium on drug ads, with 41% backing a two-year moratorium and 32% saying there should be no drug advertising at all.

Physicians and consumers were in agreement that the FDA is falling down on the job of policing DTC, with three-quarters of both groups saying the agency has failed to adequately vet ads.

Share this article:

Email Newsletters

More in News

FDA kind of OKs Lilly/BI's Lantus look-alike

FDA kind of OKs Lilly/BI's Lantus look-alike

Sanofi's patent lawsuit triggered the tentative approval of the Lilly-BI Lantus competitor.

GSK relaunches COPD.com

GSK relaunches COPD.com

The refresh launched soon after the company encouraged investors to take a long view of GSK as the firm posted weak respiratory numbers.

Six things for pharma marketers to know: Tuesday, August 19

Six things for pharma marketers to know: Tuesday, ...

Lilly/BI receives tentative approval for insulin biosimilar; Ebola death rate hits new high; LaMattina sounds off on Pfizer's oncology efforts; art therapy becoming the norm in hospitals.